Form 4: Crescent Capital BDC President Increases Stake
Insider Transaction Report
Henry Chung, President of Crescent Capital BDC, acquired 4,500 shares of common stock at $11.45 per share.
Summary
- Henry Chung, President of Crescent Capital BDC, purchased 4,500 shares of common stock on May 21, 2026.
- The transaction was executed at a price of $11.45 per share.
- Following this transaction, the reporting person's total beneficial ownership increased to 20,722 shares.
- The total includes 945 shares previously acquired through dividend reinvestment in 2026.
Sentiment
Score: 7
Explanation: StockSavvy.ai views this as a moderately positive signal, as executive stock purchases indicate internal confidence in the company's future performance.
Positives
- Insider confidence is demonstrated by the President's direct purchase of company stock.
- The acquisition increases the alignment of interests between management and shareholders.
Negatives
- None identified.
Risks
- Market price volatility of CCAP common stock.
- General risks associated with BDC investments and interest rate fluctuations.
Future Outlook
Not applicable as this is a disclosure of an insider transaction.
Industry Context
StockSavvy.ai notes that insider buying in the BDC sector is often viewed as a positive signal regarding management's belief in the underlying net asset value and dividend sustainability of the portfolio.
Comparison to Industry Standards
- Insider purchases by C-suite executives are generally viewed as a standard positive indicator of corporate health across the BDC industry.
- The purchase price of $11.45 is consistent with typical market valuations for BDCs trading near their net asset value.
Stakeholder Impact
- Shareholders may perceive this as a vote of confidence from the President.
Next Steps
- No future actions or milestones were disclosed in this filing.
Key Dates
| Date | Description |
|---|---|
| 05/21/2026 | Date of the reported stock purchase transaction. |
| 05/22/2026 | Date the Form 4 was signed and filed. |
Keywords
Crescent Capital BDC, CCAP, Insider Trading, Form 4, Stock Purchase, Business Development Company
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.